ed with other vitamins of the B group.
There have been rare reports of the following types of reactions:
Dermatologic – rash, erythema, pruritis
CNS – headache, dizziness, agitation, anxiety
Ophthalmic – diplopia
Allergic – urticaria, shortness of breath, wheezing and angioedema.
Overdosage
The fat-soluble vitamins A, D, and E can accumulate to harmful levels. The possibility of hypervitaminosis A or D should be borne in mind. Clinical manifestations of hypervitaminosis A have been reported in patients with renal failure receiving 1.5 mg/day retinol. Therefore, vitamin A supplementation of renal failure patients should be undertaken with caution.
Water-soluble vitamins are readily excreted in the urine. Treatment of vitamin overdosage usually consists of withdrawal of the vitamin.
Dosage and Administration
INFUVITE ADULT is ready for immediate use in adults and children aged 11 years and older when added to intravenous infusion fluids.
INFUVITE ADULT should not be given as a direct, undiluted intravenous injection as it may give rise to dizziness, faintness, and possible tissue irritation.
For intravenous feeding, one daily dose of INFUVITE ADULT (5 mL of Vial 1 plus 5 mL of Vial 2) added directly to not less than 500 mL, and preferably 1,000 mL, of intravenous dextrose, saline or similar infusion solutions. Discard any unused portion.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
After INFUVITE ADULT is diluted in an intravenous infusion, the resulting solution should be refrigerated unless it is to be used immediately. The solution should be used within 24 hours after dilution. Some of the vitamins in this product, particularly A, D, and riboflavin, are light sensitive, therefore, exposure to light should be minimized.
How Supplied
INFUVITE ADULT – NDC 54643-5649-1, is available in boxes containing 10 vials - 5 each of Vial 1 (5 mL) and Vial 2 (5 mL), one Vial 1 plus one Vial 2 to be used for a single dose.
Store under refrigeration, 2-8°C (36-46°F).
Rx only
Manufactured by
Sandoz Canada Inc.
145 Jules-Leger Street
Boucherville, QC, Canada J4B 7K8
Distributed by
Baxter Healthcare Corporation
Clintec Nutrition Division
Deerfield, IL 60015 USA
Printed in Canada
D1006230
Rev. September 2007
® INFUVITE is a registered trademark of Sandoz Canada Inc.
Infuvite Adult Carton
2A9018 NDC 54643-5649-1
Baxter
INFUVITE ADULT Multiple Vitamins for Infusion
For intravenous infusion after dilution only. Rx only
Sterile
Contains 5 each of Vial 1 (5 mL) and Vial 2 (5 mL).
One vial of each to be used for a single dose.
Store under refrigeration, 2-8°C (36-46°F)
ADULT INFUVITE MULTIPLE VITAMINS FOR INFUSION
asorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin 5-phosphate sodium, pyridoxine hydrochloride, niacinamide, dexpanthenol, alpha-tocopherol acetate, vitamin k1, folic acid, biotin, cyanocobalamin injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54643-5649
Route of Administration INTRAVENOUS
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID 200 mg in 10 mL
VITAMIN A PALMITATE (UNII: 1D1K |
